NCT00113113 2024-08-02Study of Rubitecan in Cancer Patients With Renal or Hepatic DysfunctionAstex Pharmaceuticals, Inc.Phase 1 Completed54 enrolled
NCT00113256 2024-08-02Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic CancerAstex Pharmaceuticals, Inc.Phase 2/3 Terminated39 enrolled